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Abstract
Cardiovascular diseases are  still the number one cause of death or invalidity in the western 
world  today.  Atherosclerotic  plaques  and  restenosis  can  result  in  severe  occlusions  of 
peripheral  and  coronary  arteries.  Treatment  depends  on  the  severity  of  the  disease  and 
includes  drug  therapy  and  bypass  surgery.  Generally,  autologous  vessels are  used  as 
replacement grafts and are the first choices as vascular graft materials. However, if the patient 
does  not  have  vessels  with  sufficient  quality,  as  a  result  of  previous  operations  or  other 
diseases, artificial  grafts  may be used to replace vessels. Today’s  materials  are limited to 
substitute  large  vessels  (>5  mm)  because  of  frequent  thrombosis  and  occlusion  of  small 
diameter  grafts.  About  10%  of  patients  with  coronary  artery  disease  are  therefore  left 
untreated.  Considering the high number of patients  in the need of replacement  grafts,  the 
demand for an alternative small-caliber graft is enormous and has driven scientist to search 
for new materials. Bacterial cellulose (BC) has unique qualities and is an interesting material 
for vascular grafts.
In  this  thesis,  bacterial  cellulose  has  been  investigated  as  a  potential  new vascular  graft 
material by evaluating cell and blood interactions with BC. The specific aims were to evaluate 
if  surface  modifications  could  promote  human  endothelial  cells  and  to  investigate  the 
thrombogenic properties of BC compared to conventional graft materials.
Modification of BC with a novel technique, were xyloglucan is used as a carrier molecule for 
the adhesion-promoting peptide RGD, resulted in increased cell  adhesion, metabolism and 
cell  spreading.  Luminal  coating  of  BC-tubes  with  fibrin  glue  resulted  in  increased  cell 
adhesion during static experiments and good cell retention during physiological shear stress. 
The evaluation of thrombogenicity in human blood plasma revealed that BC induces a slower 
coagulation compared with clinically available materials such as Gore-Tex® and Dacron®. In 
addition, BC induced the least contact activation evaluated by XIIa generation. 
A Chandler loop system with freshly drawn blood showed that BC consumed low amounts of 
platelets and generated low thrombin values compared with Dacron® and Gore-Tex®. 
This  Thesis  shows  that  BC  is  a  promising,  novel  vascular  graft  material  based  on  low 
thrombogenicity and promising endothelial cell adhesion. 
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